| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXHS1800045 | 盐酸恩莎替尼胶囊 | Ensartinib Hydrochloride | Capsule | Chemical Drugs(1) | New Drug Application | 2019-01-02 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2020-11-24 | view |
| CXHS1800046 | 盐酸恩莎替尼胶囊 | Ensartinib Hydrochloride | Capsule | Chemical Drugs(1) | New Drug Application | 2019-01-02 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2020-11-24 | view |